Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New surgical stapler put to the test in 244 patients

NCT ID NCT05519215

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 40 times

Summary

This study tested a new powered stapler (ECHELON 3000) in 244 people having either stomach reduction surgery or lung removal surgery. The main goal was to see if the device caused serious side effects like infection, bleeding, or air leaks. The study is complete and helps doctors understand how safe and effective this tool is.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC SLEEVE GASTRECTOMY (LSG) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ascension Providence Hospital

    Southfield, Michigan, 48075, United States

  • Bariatric Medical Institute of Texas

    San Antonio, Texas, 78258, United States

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

  • Emory Cardiothoracic Surgery

    Atlanta, Georgia, 30322, United States

  • George Washington University Hospital

    Washington D.C., District of Columbia, 20037, United States

  • Henry Ford Health Center

    Detroit, Michigan, 48202, United States

  • Long Island Jewish Medical Center

    New Hyde Park, New York, 11040, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

Conditions

Explore the condition pages connected to this study.